Italian Medicines Agency
Impact in
-
- Pharmaceutical Practices and Patient Outcomes
- Toxicology top 10%
- Pharmacovigilance and Adverse Drug Reactions
Papers in
- Toxicology 58
- Pharmacovigilance and Adverse Drug Reactions 58
-
- Pharmaceutical Practices and Patient Outcomes 17
- Top scholars
- Luca PaniFrancesco TrottaCarmela SantuccioGabriela MazzantiGraziano OnderPierluigi RussoRoberto RaschettiFrancesca Menniti‐Ippolito
- Journals
- British Journal of Clinical Pharmacology (14 papers)Drug Safety (12 papers)Vaccine (12 papers)Frontiers in Pharmacology (10 papers)European Journal of Clinical Pharmacology (8 papers)
- Partner nations
- ItalyNetherlandsUnited Kingdom
In The Last Decade
Italian Medicines Agency
427 papers receiving 10.9k citations
Peers
Comparison fields: 5 of 179
- Geriatrics and Gerontology 559
- Toxicology 601
- Family Practice 243
- Economics and Econometrics 1.4k
- Biochemistry 301
Countries citing scholars working at Italian Medicines Agency
This map shows the geographic impact of research produced by authors working at Italian Medicines Agency. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Italian Medicines Agency with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Italian Medicines Agency more than expected).
Fields of papers published by authors at Italian Medicines Agency
This network shows the impact of papers affiliated with Italian Medicines Agency at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Italian Medicines Agency at the time of their publication.
About Italian Medicines Agency
In recent decades, authors affiliated with Italian Medicines Agency have published 457 papers, which have received a total of 11k indexed citations . Scholars at this organization have produced 58 papers in Toxicology, 17 papers in Geriatrics and Gerontology, 10 papers in Applied Microbiology and Biotechnology, 97 papers in Economics and Econometrics and 8 papers in Family Practice on the topics of Pharmaceutical Economics and Policy (84 papers), Pharmacovigilance and Adverse Drug Reactions (58 papers), Health Systems, Economic Evaluations, Quality of Life (29 papers), Pharmaceutical studies and practices (24 papers), Biomedical Ethics and Regulation (22 papers), Pharmaceutical industry and healthcare (21 papers), Pharmaceutical Practices and Patient Outcomes (17 papers) and Statistical Methods in Clinical Trials (15 papers). Their work is cited by papers focused on Geriatrics and Gerontology (559 citations), Toxicology (601 citations), Family Practice (243 citations), Economics and Econometrics (1.4k citations) and Biochemistry (301 citations). Authors at Italian Medicines Agency collaborate with scholars in Italy, Netherlands and United Kingdom and have published in prestigious journals including British Journal of Clinical Pharmacology, Drug Safety, Vaccine, Frontiers in Pharmacology and European Journal of Clinical Pharmacology. Some of Italian Medicines Agency's most productive authors include Luca Pani, Francesco Trotta, Carmela Santuccio, Gabriela Mazzanti, Graziano Onder, Pierluigi Russo, Roberto Raschetti, Francesca Menniti‐Ippolito, Alessandra Marengoni and Valentina Mantua.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.